Reduction of Suicidality during Clozapine Treatment of Neuroleptic-Resistant Schizophrenia: Impact on Risk-Benefit Assessment

American Journal of Psychiatry

Volumn 152, Issue 2, 1995, Pages 183-190

  Meltzer, Herbert Y ^a,b   Okayli, Ghadeer ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT;

ADULT; AGRANULOCYTOSIS; ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG RESISTANCE; FEMALE; FOLLOW UP; GRANULOCYTOPENIA; HAMILTON SCALE; HELPLESSNESS; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; RISK BENEFIT ANALYSIS; SCHIZOIDISM; SCHIZOPHRENIA; SUICIDAL BEHAVIOR;

ADULT; ANTIPSYCHOTIC AGENTS; CLOZAPINE; DRUG RESISTANCE; FEMALE; FOLLOW-UP STUDIES; HUMAN; MALE; PROSPECTIVE STUDIES; RISK ASSESSMENT; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SUICIDE; SUICIDE, ATTEMPTED; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TREATMENT OUTCOME;

EID: 0028869668     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.152.2.183     Document Type: Article

References (69)

1. Bleuler E: Dementia Praecox or the Group of Schizophrenias (1911). Translated by Zinkin J. New York, International Universities Press, 1950
2. Allebeck P: Schizophrenia: a life-shortening disease. Schizophr Bull 1989; 15:81-89
3. Drake GE, Gates C, Whitaker A, Cotton PG: Suicide among schizophrenics: a review. Compr Psychiatry 1985; 26:90-100
4. Roy A: Depression, attempted suicide and suicide in patients with chronic schizophrenia. Psychiatr Clin North Am 1986; 9:193-206
5. Asnis GM, Friedman TA, Sanderson WC, Kaplan ML, van Praag HM, Harkavy-Friedman JM: Suicidal behaviors in adult psychiatric outpatients, I: description and prevalence. Am J Psychiatry 1993; 150:108-112
6. Miles C: Conditions predisposing to suicide. J Nerv Ment Dis 1977; 164:231-246
7. Black DW: Mortality in schizophrenia - the Iowa Record-Linkage Study: a comparison with general population mortality. Psychosomatics 1988; 29:55-60
8. Planansky K, Johnston R: The occurrence and characteristics of suicidal preoccupation and acts in schizophrenia. Acta Psychiatr Scand 1971; 47:473-483
9. Niskanen P, Lonnqvist S, Achte K: Schizophrenia and suicide. Psychiatria Fennica 1973; 223-227
10. Newman SC: Mortality in a cohort of patients with schizophrenia: a record linkage study. Can J Psychiatry 1991; 36:239-245
11. Nyman AK, Jonsson SH: Patterns of self-destructive behavior in schizophrenia. Acta Psychiatr Scand 1986; 73:252-262
12. Bleuler M: The Schizophrenic Disorders: Long-Term and Family Studies. New Haven, Conn, Yale University Press, 1978
13. Tsuang MT: Suicide in schizophrenics, manies, depressives and surgical controls. Arch Gen Psychiatry 1978; 35:153-154
14. Cohen LJ, Test MA, Brown RL: Suicide and schizophrenia: data from a prospective community treatment study. Am J Psychiatry 1990; 147:602-607; correction, 147:1110
15. Axelsson R, Lagerkvist-Briggs M: Factors predicting suicide in psychotic patients. Eur Arch Psychiatry Clin Neurosci 1992; 241: 259-266
16. Ehlinger R: Evaluation of suicide prevention after attempted suicide. Acta Psychiatr Scand (Suppl) 1975; 260:64-124
17. Kreitman N (ed): Parasuicide. New York, John Wiley & Sons, 1977
18. Dassori AM, Mezzick JE, Keshavan M: Suicidal indicators in schizophrenia. Acta Psychiatr Scand 1990; 81:409-413
19. Westermeyer JF, Harrow M, Marengo JT: Risk for suicide in schizophrenia and other psychotic and non-psychotic disorders. J Nerv Ment Dis 1991; 179:259-266
20. Addington DE, Addington JM: Attempted suicide and depression in schizophrenia. Acta Psychiatr Scand 1992; 85:288-291
21. Modestin J, Zarro I, Waldvogel D: A study of suicide in schizophrenic inpatients. Br J Psychiatry 1992; 160:398-401
22. Allebeck P, Varia A, Kristjansson E, Wistedt B: Risk factors for suicide among patients with schizophrenia. Acta Psychiatr Scand 1987; 76:414-419
23. Roy A: Suicide in chronic schizophrenia. Br J Psychiatry 1982; 141:171-177
24. Drake RE, Gates C, Colton PG, Whitaker A: Suicide among schizophrenics: who is at risk? J Nerv Ment Dis 1984; 172:613-617
25. Kane J, Honigfeld G, Singer J, Meltzer H: Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988; 45:789-796
26. Meltzer HY: Treatment of the neuroleptic non-responsive schizophrenic patient. Schizophr Bull 1992; 18:515-542
27. Krupp P, Barnes P: Leponex-associated granulocytopenia: a review of the situation. Psychopharmacology (Berl) 1989; 99(suppl): S118-S121
28. Devinsky O, Honigfeld G, Patin J: Clozapine-related seizures. Neurology 1991; 41:369-371
29. Endicott J, Spitzer RL: A diagnostic interview: the Schedule for Affective Disorders and Schizophrenia. Arch Gen Psychiatry 1978; 35:837-844
30. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62
31. Rhodes HM, Overall JE: The semistructured BPRS interview and rating guide. Psychopharmacol Bull 1988; 10:101-104
32. Agresti A: Analysis of Ordinal Categorical Data. New York, John Wiley & Sons, 1984
33. Agresti A: Tutorial on modeling ordered categorical response data. Psychol Bull 1989; 105:290-301
34. Koch GC, Landis JR, Freeman JL, Freeman DH, Lehnen RG: A general methodology for the analysis of experiments with repeated measurement of categorical data. Biometrics 1977; 33: 133-158
35. SAS/STAT User's Guide, version 6, 4th ed, vol 1. Cary, NC, SAS Institute, 1990
36. Koch GG, Landis JR, Freeman JL, Freeman DH, Lehnen RG: A general methodology for the analysis of experiments with repeated measurement of categorical data. Biometrics 1977; 33: 133-158
37. Peterson LG, Sanjar B: Repetitive suicidal crises. Characteristics of repeating versus non-repeating suicidal visitors to a psychiatric emergency service. Psychopathology 1990; 23:136-145
38. Yasuden M: A clinical study of suicide behavior in schizophrenic patients. Seishin Shinkeigaku Zasshi 1992; 94:135-170
39. Sletten IW, Brown ML, Evenson C, Altman H: Suicide in mental hospital patients. Dis Nerv Syst 1972; 33:328-334
40. Achte K, Stenback A, Teravainen H: On suicides committed during treatment in psychiatric hospitals. Acta Psychiatr Scand 1966; 42:272-284
41. Beisser A, Blanchette J: A study of suicides in a mental hospital. Dis Nerv Syst 1961; 22:365-369
42. Minkoff K, Bergman E, Beck AT, Beck R: Hopelessness, depression, and attempted suicide. Am J Psychiatry 1973; 130:455-459
43. Beck AT, Kovacs M, Weissman A: Hopelessness and suicidal behavior: an overview. JAMA 1975; 234:1146-1149
44. Naber D, Leppig M, Grohman R, Hippius H: Efficacy and adverse effects of clozapine in the treatment of schizophrenia and tardive dyskinesia - a retrospective study of 387 patients. Psychopharmacology (Berl) 1989; 99(suppl):S73-S76
45. Parsa M, Ramirez LF, Loula EC, Meltzer HY: Effect of clozapine on psychotic depression and Parkinsonism. J Clin Psychopharmacol 1991; 11:330-331
46. Floru L, Heinrich K, Wittek F: The problems of post-psychotic schizophrenic depressions and their pharmacological induction. Int Pharmacopsychiatry 1975; 10:230-239
47. Rifkin A, Gutkin F, Klein DF: Akinesia. Arch Gen Psychiatry 1975; 32:672-674
48. Van Putten T, May PRA: A kinetic depression in schizophrenia. Arch Gen Psychiatry 1978; 35:1101-1107
49. Denber HC: Some aspects of chlorpromazine treatment with reference to the problem of depression. Dis Nerv Syst 1957; 18:35-36
50. De Alarcon R, Carney MW: Severe depressive mood changes following slow-release intramuscular fluphenazine injection. Br Med J 1969; 3:564-567
51. Knights A, Okasha MS, Salih MA, Hirsch SR: Depressive and extrapyramidal symptoms and clinical effects: a trial of fluphenazine versus flupenthixol in maintenance of schizophrenic outpatients. Br J Psychiatry 1979; 135:515-523
52. Hogan TO, Awad AG: Pharmacotherapy and suicide risk in schizophrenia. Can J Psychiatry 1983; 28:277-281
53. Meltzer HY, Burnett S, Bastani B, Ramirez LF: Effect of six months of clozapine treatment on the quality of life of chronic schizophrenic patients. Hosp Community Psychiatry 1990; 41: 892-897
54. Hagger C, Buckley P, Kenny JT, Friedman L, Ubogy D, Meltzer HY: Improvement in cognitive function and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine. Biol Psychiatry 1993; 34:702-712
55. Meltzer HY: Dimensions of outcome with clozapine. Br J Psychiatry 1992; 160(suppl 17):46-53
56. Meltzer HY, Cola P, Way L, Thompson PA, Bastani B, Davies MA, Snitz B: Cost effectiveness of clozapine in neuroleptic-resistant schizophrenia. Am J Psychiatry 1993; 150:1630-1638
57. Beck AT, Steer RA, Kovacs M, Garrison B: Hopelessness and eventual suicide: a 10-year prospective study of patients hospitalized with suicidal ideation. Am J Psychiatry 1985; 142:559-563
58. Johns CA, Stanley M, Stanley B: Suicide in schizophrenia. Ann NY Acad Sci 1986; 487:294-300
59. Beck RE: Depression in schizophrenia. Hosp Community Psychiatry 1988; 39:1269-1275
60. Davis JM: Recent developments in the drug treatment of schizophrenia. Am J Psychiatry 1976; 133:208-214
61. Alvir JMJ, Lieberman JA, Safferman AZ, Schwimmer JL, Schaof JA: Clozapine-induced agranulocytosis incidence and risk factors in the United States. N Engl J Med 1993; 329:162-167
62. Solomon P: The admissions process in two state psychiatric hospitals. Hosp Community Psychiatry 1981; 32:405-408
63. Hawton K, Fagg J: Suicide and other causes of death, following attempted suicide. Br J Psychiatry 1988; 152:359-366
64. Maris RW: Pathways to Suicide: A Survey of Self-Destructive Behaviors. Baltimore, Johns Hopkins University Press, 1981
65. Fawcett J, Scheftner W, Clark D, Hedeker D, Gibbons R, Coryell W: Clinical predictors of suicide in patients with major affective disorders: a controlled prospective study. Am J Psychiatry 1987; 144:35-40
66. Dorpat TL, Ripley HS: The relationship between attempted suicide and committed suicide. Compr Psychiatry 1967; 8:74-79
67. Casey DE: Clozapine: neuroleptic-induced EPS and tardive dyskinesia. Psychopharmacology (Berl) 1989; 99(suppl):S47-S53
68. McClelland HA, Dutta D, Metcalfe A, Kerr TA: Mortality and facial dystonia. Br J Psychiatry 1986; 148:310-316
69. Youseff HA, Waddington JL: Morbidity and mortality in tardive dyskinesia: associations in chronic schizophrenia. Acta Psychiatr Scand 1987; 15:74-77